Bristol Myers Squibb is exploring the potential of a decades-old drug to treat Alzheimer's disease. The company's interest in this drug is reported, but details about the drug and its development are not specified. Other recent news about the company includes announcements about new treatments and the company's overall strategy, but it is unclear how these developments relate to the potential Alzheimer's treatment.